Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Rag D Inhibitors

Rag D inhibitors belong to a class of small molecules that are designed to modulate the activity of the Rag D protein, which is a crucial component of the Rag GTPase family. The Rag GTPases play a pivotal role in regulating the mechanistic target of rapamycin complex 1 (mTORC1) pathway, a central signaling cascade in cellular growth and metabolism. Specifically, Rag D is one of the four GTPase subunits within the Rag complex, and its activation state dictates the nucleotide binding and interaction with other Rags. These interactions are vital in controlling mTORC1 activation in response to nutrient availability and cellular stress.

Rag D inhibitors function by targeting the activation or nucleotide-binding site of Rag D, thereby influencing the Rag complex's ability to transmit signals to mTORC1. These molecules are designed to interfere with the formation of active Rag complexes, preventing mTORC1 activation and subsequent downstream signaling events. This disruption can have profound effects on cellular processes, such as protein synthesis, autophagy, and nutrient sensing, making Rag D inhibitors valuable tools for investigating the intricate regulatory mechanisms governing cell growth and homeostasis.Researchers utilize Rag D inhibitors primarily in laboratory settings to gain insights into the molecular pathways that govern cellular responses to environmental cues. By manipulating the Rag D protein's activity, scientists can elucidate the role of mTORC1 signaling in various cellular processes and uncover novel targets for conditions related to dysregulated cell growth and metabolism.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ibrutinib

936563-96-1sc-483194
10 mg
$153.00
5
(0)

Irreversibly binds to Bruton's tyrosine kinase (BTK), inhibiting B-cell receptor signaling, and disrupting the survival and proliferation of B-cells.

ABT-199

1257044-40-8sc-472284
sc-472284A
sc-472284B
sc-472284C
sc-472284D
1 mg
5 mg
10 mg
100 mg
3 g
$116.00
$330.00
$510.00
$816.00
$1632.00
10
(0)

Selectively inhibits B-cell lymphoma-2 (BCL-2) protein, promoting apoptosis in cancer cells by blocking the anti-apoptotic function of BCL-2.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$62.00
$112.00
$214.00
$342.00
74
(2)

Targets and inhibits the epidermal growth factor receptor (EGFR) tyrosine kinase, blocking downstream signaling pathways in cancer cells.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$25.00
$117.00
$209.00
27
(1)

Acts as a tyrosine kinase inhibitor, primarily targeting BCR-ABL, the abnormal fusion protein found in chronic myeloid leukemia (CML).

Osimertinib

1421373-65-0sc-507355
5 mg
$86.00
(0)

Specifically inhibits mutant forms of EGFR, which are common in non-small cell lung cancer (NSCLC), blocking tumor growth.

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$206.00
$299.00
$485.00
10
(1)

Inhibits poly (ADP-ribose) polymerase (PARP) enzymes, leading to DNA damage accumulation and cell death in BRCA-mutated cancer cells.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

Targets multiple kinases, including BCR-ABL and Src family kinases, disrupting signaling pathways in leukemia and other cancers.

CH5424802

1256580-46-7sc-364461
sc-364461A
5 mg
50 mg
$191.00
$902.00
(0)

Selectively inhibits anaplastic lymphoma kinase (ALK), which is implicated in certain types of lung cancer, leading to tumor regression.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

Inhibits multiple kinases, including RAF and VEGFR, blocking angiogenesis and cell proliferation in various cancers.

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$128.00
$638.00
7
(1)

Inhibits mTOR (mammalian target of rapamycin) signaling, reducing cell growth and proliferation in cancer and immunosuppression.